Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of ctDNA Assay in the Neoadjuvant and Adjuvant Chemotherapy Setting in Patients With Resectable Pancreatic Cancer

NCT05052671 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05052671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of ctDNA Assay in the Neoadjuvant and Adjuvant Chemotherapy Setting in Patients With Resectable Pancreatic Cancer
Lead sponsor
University of Oklahoma
Phase
Observational
Overall status
Recruiting
Start date
May 25, 2022
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer